Desvenlafaxine-Associated Hyperglycemia: A Case Report and Literature Review | May 2020

Articles

Mental Health Clinician

https://doi.org/10.9740/mhc.2020.05.085

Venlafaxine and Desvenlafaxine in the Management of Menopausal Hot Flashes | September 2011

Articles

NCBI>Pharmacy Practice

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3870169/

Desvenlafaxine versus Placebo in a Fluoxetine-Referenced Study of Children and Adolescents with Major Depressive Disorder | February 2018

Articles

Journal of Child and Adolescent Psychopharmacology

https://www.liebertpub.com/doi/10.1089/cap.2017.0100

A Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Desvenlafaxine Succinate in the Treatment of Major Depressive Disorder | May 2007

Abstracts

Journal of Clinical Psychiatry

https://doi.org/10.4088/jcp.v68n0504

Desvenlafaxine Compared with Placebo for Treatment of Menopausal Vasomotor Symptoms: A 12-Week, Multicenter, Parallel-Group, Randomized, Double-Blind, Placebo-Controlled Efficacy Trial | January 2013

Abstracts

Menopause

https://doi.org/10.1097/gme.0b013e31826421a8

An Open-Label, Single-Dose, Parallel-Group Study of the Effects of Chronic Hepatic Impairment on the Safety and Pharmacokinetics of Desvenlafaxine | April 2013

Abstracts

Clinical Therapeutics

https://doi.org/10.1016/j.clinthera.2013.03.013

Early Improvement in Depressive Symptoms with Desvenlafaxine 50 Mg/d as a Predictor of Treatment Success in Patients with Major Depressive Disorder | February 2014

Abstracts

Journal of Clinical Psychopharmacology

https://journals.lww.com/psychopharmacology/Abstract/2014/02000/Early_Improvement_in_Depressive_Symptoms_With.12.aspx

Efficacy of Desvenlafaxine 50 Mg/d versus Placebo in the Long-Term Treatment of Major Depressive Disorder: A Randomized, Double-Blind Trial | August 2015

Articles

Primary Care Companion for CNS Disorders

http://dx.doi.org/10.4088/PCC.14m01711

A Randomized, Double-Blind, Placebo-Controlled Trial of Desvenlafaxine Succinate in Adult Outpatients with Major Depressive Disorder | November 2007

Abstracts

Journal of Clinical Psychiatry

https://doi.org/10.4088/jcp.v68n1105

Open-Label Desvenlafaxine as Monotherapy for Persistent Depression Disorder: A Pilot Study (Meetings-Events) | June 2016

Abstracts

International Journal of Neuropsychopharmacology

https://doi.org/10.1093/ijnp/pyw043.100

The Effect of Desvenlafaxine 50 Mg/Day on a Subpopulation of Anxious/Depressed Patients: A Pooled Analysis of Seven Randomized, Placebo-Controlled Studies | August 2014

Abstracts

Human Psychopharmacology: Clinical and Experimental

https://onlinelibrary.wiley.com/doi/10.1002/hup.2427

Desvenlafaxine versus Venlafaxine for the Treatment of Adult Patients with Major Depressive Disorder: A Review of the Comparative Clinical and Cost-Effectiveness | October 2017

Publications (Books-Reports)

Canadian Agency for Drugs and Technologies in Health

https://www.cadth.ca/desvenlafaxine-versus-venlafaxine-treatment-adult-patients-major-depressive-disorder-review-0

Improvement in Quality of Life of Postmenopausal Women with Depression with Commonly Used Antidepressants (Escitalopram vs. Desvenlafaxine): A Randomized Controlled Trial in a Tertiary Care Teaching Hospital of North India | May 2022

Articles

Journal of Mid-Life Health

https://www.jmidlifehealth.org/text.asp?2022/13/1/80/344562

An Analysis of Relapse Rates and Predictors of Relapse in 2 Randomized, Placebo-Controlled Trials of Desvenlafaxine for Major Depressive Disorder | February 2015

Articles

Primary Care Companion for CNS Disorders

http://dx.doi.org/10.4088/PCC.14m01681

Drug-Drug Interactions Involving Antidepressants: Focus on Desvenlafaxine | February 2018

Articles

Neuropsychiatric Disease and Treatment

https://www.dovepress.com/drug-drug-interactions-involving-antidepressants-focus-on-desvenlafaxi-peer-reviewed-article-NDT

BDNF, Interleukin-6, and Salivary Cortisol Levels in Depressed Patients Treated with Desvenlafaxine | October 2013

Abstracts

Progress in Neuro-Psychopharmacology and Biological Psychiatry

https://www.sciencedirect.com/science/article/abs/pii/S027858461300211X

Pharmacotherapy of Major Depressive Disorder: Focus on Desvenlafaxine Succinate | April 2010

Articles

Clinical Medicine Insights: Therapeutics

http://journals.sagepub.com/doi/full/10.4137/CMT.S74

A 10-Month, Open-Label Evaluation of Desvenlafaxine in Japanese Outpatients with Major Depressive Disorder | July 2013

Abstracts

International Clinical Psychopharmacology

https://journals.lww.com/intclinpsychopharm/Abstract/2013/07000/A_10_month,_open_label_evaluation_of.8.aspx

Efficacy of Desvenlafaxine Succinate for Menopausal Hot Flashes | September 2014

Abstracts

Expert Opinion on Pharmacotherapy

https://www.tandfonline.com/doi/abs/10.1517/14656566.2014.964641

Speed of Improvement in Symptoms of Depression with Desvenlafaxine 50 mg and 100 mg Compared with Placebo in Patients with Major Depressive Disorder | October 2017

Articles

Journal of Clinical Psychopharmacology

https://journals.lww.com/psychopharmacology/Fulltext/2017/10000/Speed_of_Improvement_in_Symptoms_of_Depression.13.aspx

Categorical Improvement in Functional Impairment in Depressed Patients Treated with Desvenlafaxine | November 2017

Articles

CNS Spectrums

https://doi.org/10.1017/S1092852917000633

Desvenlafaxine for the Acute Treatment of Depression: A Systematic Review and Meta-Analysis | July 2015

Abstracts

Pharmacopsychiatry

https://www.thieme-connect.com/products/ejournals/abstract/10.1055/s-0035-1555879

An Indirect Comparison of the Efficacy and Safety of Desvenlafaxine and Venlafaxine Using Placebo as the Common Comparator | August 2012

Abstracts

CNS Spectrums

https://doi.org/10.1017/s1092852912000648

Predictors of Functional Response and Remission with Desvenlafaxine 50 Mg/D in Patients with Major Depressive Disorder | February 2014

Abstracts

CNS Spectrums

https://doi.org/10.1017/s1092852914000066

A Pilot, Open-Label, 8-Week Study Evaluating Desvenlafaxine for Treatment of Major Depression in Methadone-Maintained Individuals with Opioid Use Disorder | September 2018

Abstracts

International Clinical Psychopharmacology

https://doi.org/10.1097/yic.0000000000000223

Key Differences between Venlafaxine XR and Desvenlafaxine: An Analysis of Pharmacokinetic and Clinical Data | January 2014

Articles

Mental Health Clinician

https://doi.org/10.9740/mhc.n186977

Post Hoc Analysis of the Efficacy and Safety of Desvenlafaxine 50 Mg/Day in a Randomized, Placebo-Controlled Study of Perimenopausal and Postmenopausal Women with Major Depressive Disorder | August 2014

Abstracts

Menopause

https://doi.org/10.1097/gme.0000000000000178

Efficacy and Safety of Desvenlafaxine Treatment for Hot Flashes Associated with Menopause: A Meta-Analysis of Randomized Controlled Trials | March 2013

Abstracts

Gynecologic and Obstetric Investigation

https://doi.org/10.1159/000348564

Efficacy, Tolerability, and Safety of Toludesvenlafaxine for the Treatment of Major Depressive Disorder-A Narrative Review | March 2023

Articles

Pharmaceuticals

https://www.mdpi.com/1424-8247/16/3/411

A Double-Blind, Randomized, Placebo-Controlled Study Assessing the Efficacy and Tolerability of Desvenlafaxine 10 and 50 Mg/Day in Adult Outpatients with Major Depressive Disorder | March 2013

Articles

BMC Psychiatry

https://bmcpsychiatry.biomedcentral.com/articles/10.1186/1471-244X-13-94

Incidence and Timing of Taper/Posttherapy-Emergent Adverse Events Following Discontinuation of Desvenlafaxine 50 Mg/D in Patients with Major Depressive Disorder | February 2015

Articles

Primary Care Companion for CNS Disorders

http://dx.doi.org/10.4088/PCC.14m01715

Desvenlafaxine in Major Depressive Disorder: An Evidence-Based Review of Its Place in Therapy | June 2009

Articles

Core Evidence

https://www.dovepress.com/desvenlafaxine-in-major-depressive-disorder-an-evidence-based-review-o-peer-reviewed-article-CE

The Relationship between Plasma Serotonin and Kynurenine Pathway Metabolite Levels and the Treatment Response to Escitalopram and Desvenlafaxine | January 2020

Articles

Brain, Behavior, and Immunity

https://www.sciencedirect.com/science/article/pii/S0889159119306622

Desvenlafaxine as the Main Possible Culprit in Triggering Reversible Cerebral Vasoconstriction Syndrome: A Case Report | September 2022

Articles

Cureus

https://doi.org/10.7759/cureus.29780

Treatment Options for Vasomotor Symptoms in Menopause: Focus on Desvenlafaxine | July 2012

Articles

International Journal of Women’s Health

https://www.dovepress.com/treatment-options-for-vasomotor-symptoms-in-menopause-focus-on-desvenl-peer-reviewed-article-IJWH

Clinical Effectiveness and Safety of Escitalopram and Desvenlafaxine in Patients of Depression with Anxiety: A Randomized, Open-Label Controlled Trial | July 2014

Articles

Indian Journal of Pharmacology

http://www.ijp-online.com/text.asp?2014/46/4/433/135959

Desvenlafaxine Succinate Identifies Novel Antagonist Binding Determinants in the Human Norepinephrine Transporter | November 2007

Articles

Journal of Pharmacology and Experimental Therapeutics

http://jpet.aspetjournals.org/content/323/2/720.full

Efficacy and Safety of Escitalopram, Desvenlafaxine, and Vortioxetine in the Acute Treatment of Anxious Depression: A Randomized Rater-Blinded 6-Week Clinical Trial | February 2023

Articles

Clinical Psychopharmacology and Neuroscience

https://www.cpn.or.kr/journal/view.html?doi=10.9758/cpn.2023.21.1.135

The Effects of Desvenlafaxine on Neurocognitive and Work Functioning in Employed Outpatients with Major Depressive Disorder | May 2016

Abstracts

Journal of Affective Disorders

https://www.sciencedirect.com/science/article/abs/pii/S0165032716301422

Desvenlafaxine in the Treatment of Major Depressive Disorder | February 2009

Articles

Neuropsychiatric Disease and Treatment

https://www.dovepress.com/articles.php?article_id=2877

Desvenlafaxine 50 and 100 mg/d versus Placebo for the Treatment of Major Depressive Disorder: A Phase 4, Randomized Controlled Trial | May 2015

Abstracts

Journal of Clinical Psychiatry

https://doi.org/10.4088/jcp.13m08978

An Evaluation of Sexual Functioning in Employed Outpatients with Major Depressive Disorder Treated with Desvenlafaxine 50 Mg or Placebo | December 2015

Abstracts

Journal of Sexual Medicine

https://www.sciencedirect.com/science/article/abs/pii/S1743609515303015

Abrupt Discontinuation Compared with a 1-Week Taper Regimen in Depressed Outpatients Treated for 24 Weeks with Desvenlafaxine 50 Mg/D | June 2014

Abstracts

Journal of Clinical Psychopharmacology

https://doi.org/10.1097/jcp.0000000000000100

Pharmacokinetics and Tolerability of Single-Ascending Doses of Desvenlafaxine Administered to Children and Adolescents with Major Depressive Disorder | December 2016

Abstracts

Journal of Child and Adolescent Psychopharmacology

https://www.liebertpub.com/doi/10.1089/cap.2016.0009

A 10-Month, Open-Label Evaluation of Desvenlafaxine in Outpatients with Major Depressive Disorder | April 2011

Articles

Primary Care Companion for CNS Disorders

http://dx.doi.org/10.4088/PCC.10m00977

Clinical Experience with Desvenlafaxine in Treatment of Pain Associated with Diabetic Peripheral Neuropathy | June 2014

Articles

Journal of Pain Research

https://www.dovepress.com/clinical-experience-with-desvenlafaxine-in-treatment-of-pain-associate-peer-reviewed-article-JPR

Efficacy and Safety of Escitalopram versus Desvenlafaxine in the Treatment of Major Depression: A Preliminary 1-Year Prospective Randomized Open Label Comparative Trial | January 2016

Articles

Perspectives in Clinical Research

http://www.picronline.org/text.asp?2016/7/1/45/173771

Concordance between Actual and Pharmacogenetic Predicted Desvenlafaxine Dose Needed to Achieve Remission in Major Depressive Disorder: A 10-Week Open-Label Study | January 2017

Articles

Pharmacogenetics and Genomics

https://journals.lww.com/jpharmacogenetics/Fulltext/2017/01000/Concordance_between_actual_and_pharmacogenetic.1.aspx

Acute Efficacy and Safety of Escitalopram versus Desvenlafaxine and Vortioxetine in the Treatment of Depression with Cognitive Complaint: A Rater-Blinded Randomized Comparative Study | April 2022

Articles

Psychiatry Investigation

https://www.psychiatryinvestigation.org/journal/view.php?doi=10.30773/pi.2021.0368

Desvenlafaxine versus Placebo in the Treatment of Children and Adolescents with Major Depressive Disorder | February 2018

Articles

NCBI>Journal of Child and Adolescent Psychopharmacology

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5771531/